Locally applied antibiotic and antimicrobial agents that reduce surface bioburden and control localized wound infection.
Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities. Topical antibiotic and antimicrobial treatments work by delivering an antimicrobial agent at high local concentration directly to the wound surface, where it reduces the bacterial load without the systemic exposure of oral or intravenous antibiotics. Different agents act through different mechanisms — silver and iodine disrupt microbial cell membranes and metabolism across a broad spectrum, honey works through osmotic and low-pH effects, and targeted topical antibiotics inhibit specific bacterial processes. The clinician matches the agent to the organisms and tissue involved, uses it for a defined course to avoid resistance and cytotoxicity, and reassesses whether systemic therapy is needed if infection extends beyond the wound surface.
A licensed clinician determines whether this treatment is appropriate after evaluating the wound and the patient's medical history.
Treatment decisions are individualized. Potential contraindications and precautions may include:
The clinician cleanses the wound, assesses the tissue and any signs of infection, and selects the most appropriate topical agent or antimicrobial dressing for the situation. The agent is applied in a thin, measured amount or as a dressing, and covered with an appropriate secondary dressing. The clinician defines a specific treatment course rather than open-ended use, monitors the wound's response at each visit, and escalates to systemic antibiotics or further testing if infection is not controlled or appears to be spreading.
Guidance from the Infectious Diseases Society of America (IDSA) and international wound care consensus documents supports the targeted use of topical antimicrobials for localized wound infection and critical colonization, while emphasizing antimicrobial stewardship — limiting duration of use, avoiding indiscriminate application, and reserving systemic antibiotics for infection that extends into deeper tissue. Published literature supports silver, cadexomer iodine, and medical-grade honey as effective options for reducing surface bioburden when used appropriately.
Topical agents are appropriate for localized infection or heavy bacterial burden confined to the wound surface. When infection spreads into surrounding tissue (cellulitis), bone (osteomyelitis), or the bloodstream, systemic oral or intravenous antibiotics are required instead of, or in addition to, topical treatment.
They are antimicrobials rather than traditional antibiotics. Silver and iodine act broadly against many organisms by disrupting their cell function, whereas antibiotics like mupirocin target specific bacterial processes. The clinician selects the agent that best fits the wound and organisms present.
Yes. Prolonged or indiscriminate use can promote antibiotic resistance, cause contact allergies, and be toxic to the healing cells in the wound bed. This is why clinicians prescribe a defined course and reassess regularly rather than using them indefinitely.
Yes. Medical-grade honey is processed and sterilized for wound use and works through osmotic draw and a low-pH environment that is unfavorable to bacteria. It is a recognized option for reducing bioburden in appropriate wounds — different from the honey sold as food.
Yes. The clinician reviews your full medication list and allergies before selecting a topical agent, documents the plan, and shares it with your primary care physician and care team to avoid interactions and ensure appropriate stewardship.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.